The latest news and updates on Sooma tDCS™, neurostimulation treatment, and what’s happening at Sooma Medical.
FDA approved tDCS for at-home depression treatment
Read more
Science round-up webinar: tDCS in Depression and Chronic Pain – Clinical Advancements 2025
Read more
Sooma launches direct-to-patient brain stimulation therapy for depression and chronic pain in Finland and Germany
Read more
Sooma Announces Medical Technology Expert Andreas Hartlep as New CEO
Read more
TGA approves Sooma’s at-home brain stimulation for depression in Australia
Read more
Sooma Medical Announces Pivotal FDA IDE Clinical Trial for At-Home Brain Stimulation Device for Depression Treatment
Read more
Sooma Pioneers the Integration of Brain Stimulation into Primary Care, Improving Access to Early-Stage Depression Treatment
Read more
Sooma Partners with JSTT to Introduce Brain Stimulation Treatments in Occupational Healthcare
Read more
Prioritizing Youth Mental Health: A Call to Action
Read more
Sooma Secures €5M Funding for At-home Brain Stimulation Therapies
Read more